16 May Rethinking the Appraisal and Approval of Drugs for Fracture Prevention
After decades of widespread use, effectiveness of drugs for osteoporosis remains uncertain, yet adverse effects are more apparent. Well-designed and large trials over prolonged follow-up periods, measuring clinically relevant outcomes as hip and other disabling...